Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Normal weight, hidden danger: new study seeks to unmask 'Skinny Fat' risk

NCT ID NCT07358533

Knowledge-focused Sponsor: Pomeranian Medical University Szczecin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at a condition called 'metabolically obese normal weight' (MONW), where people have a healthy BMI but too much body fat, raising their risk for heart problems and diabetes. Researchers will study 176 young women with normal weight, measuring body fat, blood markers, and blood vessel function. The goal is to find better ways to diagnose this hidden condition early.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better ways to identify people who are at risk for heart disease and diabetes even though they have a normal weight.
What could go wrong
This is an observational study, not a treatment trial. It may not find clear markers, and results may not apply to men or older women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 176 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy women aged 18-35 years with a normal body weight (BMI \<25 kg/m²) recruited from the West Pomeranian region (Poland).

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Written, informed consent to participate in the research. * Gender: Female. * Age 18-35 years. * BMI in the range of 18.5-25 kg/m². Exclusion Criteria: * Thyroid disease. * Pregnancy or breastfeeding. * Eating disorders. * Polycystic ovary syndrome (PCOS). * Hormone therapy and/or use of hormonal contraceptives. * Smoking. * Metal or silicone implants (contraindication for DXA/body composition accuracy). * Vitamin and/or mineral supplementation. * Acute and/or chronic illnesses. * Type I or II diabetes, dyslipidemia, hypertension. * Use of hypolipemic, antihypertensive, antiglycemic, or insulin medications.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Arachnodactyly metabolic disease metabolic syndrome X

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metabolic syndrome Metabolically obese normal weight Normal-weight obesity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Pomeranian Medical University in Szczecin

    Szczecin, West Pomeranian Voivodeship, 70-204, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.